Composition GHRP-2 Tesamorelin MGF (IGF-1Ec) Ipamorelin Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined pathway evaluation of GHRH analog + IGF-1Ecrelated peptide + GHS agonists (GHRP-2 and Ipamorelin) in in-vitro or ex-vivo models Assay development, including chromatographic separation of four co-formulated peptides Stability characterization of a four-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments For qualified research professionals and institutional laboratories
M/S EGMEDI | GSTIN: 07AMZPK2533P1Z8 WB-1 ground floor, Shakarpur, New Delhi-110092, India 2016-2025 All Rights Reserved by EGMEDI In compliance with Drugs and Cosmetics Act 1940 and Drugs and Cosmetics Rules 1945 , we do not process requests for Schedule X and other habit forming drugs.
DFO (4060 mg/kg/day) significantly reduces serum transferrin saturation in stroke patients and has a positive effect on patients with moderate to severe ischemic stroke
Soft start inrush current limit
Both products contain overlapping micronutrients, including zinc, iron and selenium, and combining them risks exceeding safe upper intake levels
